In his new role, Mr. Hess will be managing, developing and maintaining the pipeline for InVivo’s entire product line. He will also lead the transition of InVivo’s technologies from research and development into clinical trials and production manufacturing.
During his time with Stryker, Mr. Hess led development teams through the FDA clearance process and won multiple awards for his work.
Related Articles on Orthopedic Devices:
Medtronic’s Biologics Business Down 20% in 3Q With Infuse Sales Dropping
Arthrex Launches Compact Video Imaging System
ArthroCare Revenues Down in 2011
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.